7-21894919-G-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001277115.2(DNAH11):āc.12969G>Cā(p.Gln4323His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAH11 | NM_001277115.2 | c.12969G>C | p.Gln4323His | missense_variant | 79/82 | ENST00000409508.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAH11 | ENST00000409508.8 | c.12969G>C | p.Gln4323His | missense_variant | 79/82 | 5 | NM_001277115.2 | P1 | |
DNAH11 | ENST00000479878.1 | n.340G>C | non_coding_transcript_exon_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000697 AC: 106AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000923 AC: 23AN: 249260Hom.: 0 AF XY: 0.0000887 AC XY: 12AN XY: 135224
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461704Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727134
GnomAD4 genome AF: 0.000696 AC: 106AN: 152298Hom.: 0 Cov.: 33 AF XY: 0.000859 AC XY: 64AN XY: 74480
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2024 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 27, 2013 | The Gln4323His variant in DNAH11 has not been previously identified in individua ls with pulmonary disease. This variant has been identified in 1/2178 chromosome s from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.g ov/variation/tools/1000genomes/; dbSNP rs191802172). Glutamine at position 4223 is not well conserved in evolution, and the variant residue (Histidine) has been observed in one mammalian species (Egyptian Jerboa), suggesting that the change may be tolerated. Additional computational analyses (biochemical amino acid pro perties, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or ag ainst an impact to the protein. In summary, additional information is needed to fully assess its clinical significance. - |
Primary ciliary dyskinesia 7 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 10, 2022 | - - |
DNAH11-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 15, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at